Latest Pharmaceuticals News
Filter By Region
Pharmaceuticals
Other Industries
Filter By Price
Reports By Industry
Pharmaceuticals
UMI offers detailed comprehensive insights on various indications, different targets, and mechanism of action across various therapeutic areas for the pharmaceutical industry including detailed competitive and pipeline product profiles analysis through secondary research techniques
| List of Reports |
|---|
COVID-19 – Pipeline Analysis 2020 for Global Market
COVID-19 (also known as Anderson COVID-19) is a viral disease caused by RNA virus, SARS-CoV-2 or commonly known as corona virus. These viruses can cause respiratory, enteric, hepatic, and neurologic diseases. At the end of 2019, a new coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, China. Read More... Published:
Apr 2020,
Single User License:
$2000
|
Regenerative Medicine Market: Current Analysis and Forecast (2020-2026)
Global Regenerative Medicine Market was valued at US$ 29.1 billion in 2019 and is anticipated to reach US$ 178.6 billion by 2026 displaying reasonable CAGR of 31.5% over the forecast period (2020-2026). Regenerative Medicine refers to a group of biomedical approaches to clinical therapies that may Read More... Published:
Mar 2020,
Single User License:
$3500
|
Global Fabry Disease - Competitive Analysis 2019
Fabry Disease (also known as Anderson Fabry Disease) is a progressive X linked inherited genetic disorder of glycosphingolipid metabolism due to deficient or absent lysosomal α-galactosidase A activity. It is a devastating inborn error of metabolism with, particularly in the early stages, being played by cellular dysf Read More... Published:
Jun 2019,
Single User License:
$1,500
|
Global Myasthenia Gravis - Competitive Analysis 2019
Myasthenia Gravis (MG) is the prototype neuromuscular disease with the immunological pathogenesis. It is an acquired autoimmune disease affecting synaptic transmission via the neuromuscular junction mainly due to the presence of autoantibodies against the acetylcholine receptors (AChR) between the synaptic space of the skeletal muscles. It Read More... Published:
Jun 2019,
Single User License:
$1400
|
Global Myasthenia Gravis - Pipeline Analysis 2019
Myasthenia Gravis (MG) is the prototype neuromuscular disease with the immunological pathogenesis. It is an acquired autoimmune disease affecting synaptic transmission via the neuromuscular junction mainly due to the presence of autoantibodies against the acetylcholine receptors (AChR) between the synaptic space of the skel Read More... Published:
Jun 2019,
Single User License:
$2,000
|
Global Niemann Pick Type C Disease - Pipeline Analysis 2019
Niemann Pick Type-C Disease (NPC) is a progressive autosomal recessive genetic disorder of lysosome storage due to an inability of the body to transport cholesterol and other fatty substances (lipids) inside of cells. The accumulation of these substances damages the affected areas. It can range from a fatal disorder within Read More... Published:
Jun 2019,
Single User License:
$1,050
|
Global Niemann Pick Type C Disease - Competitive Analysis 2019
Niemann Pick Type-C Disease (NPC) is a progressive autosomal recessive genetic disorder of lysosome storage due to an inability of the body to transport cholesterol and other fatty substances (lipids) inside of cells. The accumulation of these substances damages the affected areas. It can range from a fatal disorder within Read More... Published:
Jun 2019,
Single User License:
$1,500
|
Global Adrenoleukodystrophy (ALD) - Pipeline Analysis, 2019
Adrenoleukodystrophy is a fatal progressive neurogenerative disorder affecting brain white matter. The common form of ALD is X-linked (X-ALD) and results from mutation of ABCD1 encoded very long chain fatty acid (VLCFA) transporter. It is clinically heterogeneous with the cerebral form being the most severe. X-linked Adreno Read More... Published:
Jun 2019,
Single User License:
$1,500
|